Enhanced SARS-CoV-2 Antibody Response After a Third Heterologous Vector Vaccine Ad26COVS1 Dose in mRNA Vaccine-Primed Kidney Transplant Recipients

Overview of attention for article published in Transplant International, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,326 followers.

RT @FrontPartners: 🔎Today for #TransplantTuesday Interested in #antibody responses to heterologous 3-dose vaccinations for kidney transpl…

RT @FrontPartners: 🔎Today for #TransplantTuesday Interested in #antibody responses to heterologous 3-dose vaccinations for kidney transpl…

RT @FrontPartners: 🔎Today for #TransplantTuesday Interested in #antibody responses to heterologous 3-dose vaccinations for kidney transpl…

🔎Today for #TransplantTuesday Interested in #antibody responses to heterologous 3-dose vaccinations for kidney transplant recipients? J Schimp, T Davidovic, A Abbassi-Nik, et al's research is here ➡️https://t.co/2fS3N5LZkA @ESOTtransplant @Transpl_

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.